These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27718358)

  • 1. E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent.
    Ahmadi MK; Fang L; Moscatello N; Pfeifer BA
    Metab Eng; 2016 Nov; 38():382-388. PubMed ID: 27718358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants.
    Qi R; Pfeifer BA; Zhang G
    Front Microbiol; 2018; 9():2241. PubMed ID: 30294315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic engineering of
    Li R; Peng Y; Ma L; Wang Q
    Sheng Wu Gong Cheng Xue Bao; 2023 Aug; 39(8):3290-3301. PubMed ID: 37622361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering nonphosphorylative metabolism to synthesize mesaconate from lignocellulosic sugars in Escherichia coli.
    Bai W; Tai YS; Wang J; Wang J; Jambunathan P; Fox KJ; Zhang K
    Metab Eng; 2016 Nov; 38():285-292. PubMed ID: 27697562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic engineering of TCA cycle for optimal production of a four-carbon platform chemical 4-hydroxybutyric acid in Escherichia coli.
    Choi S; Kim HU; Kim TY; Lee SY
    Metab Eng; 2016 Nov; 38():264-273. PubMed ID: 27663752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine zipper-mediated targeting of multi-enzyme cascade reactions to inclusion bodies in Escherichia coli for enhanced production of 1-butanol.
    Han GH; Seong W; Fu Y; Yoon PK; Kim SK; Yeom SJ; Lee DH; Lee SG
    Metab Eng; 2017 Mar; 40():41-49. PubMed ID: 28038953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous biosynthesis and manipulation of alkanes in Escherichia coli.
    Cao YX; Xiao WH; Zhang JL; Xie ZX; Ding MZ; Yuan YJ
    Metab Eng; 2016 Nov; 38():19-28. PubMed ID: 27267408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli.
    Harder BJ; Bettenbrock K; Klamt S
    Metab Eng; 2016 Nov; 38():29-37. PubMed ID: 27269589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotin-independent strains of Escherichia coli for enhanced streptavidin production.
    Jeschek M; Bahls MO; Schneider V; Marlière P; Ward TR; Panke S
    Metab Eng; 2017 Mar; 40():33-40. PubMed ID: 28062280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of Escherichia coli for microbial synthesis of monolignols.
    Chen Z; Sun X; Li Y; Yan Y; Yuan Q
    Metab Eng; 2017 Jan; 39():102-109. PubMed ID: 27816771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli.
    Lin Y; Sun X; Yuan Q; Yan Y
    Metab Eng; 2014 May; 23():62-9. PubMed ID: 24583236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway construction and metabolic engineering for fermentative production of ectoine in Escherichia coli.
    Ning Y; Wu X; Zhang C; Xu Q; Chen N; Xie X
    Metab Eng; 2016 Jul; 36():10-18. PubMed ID: 26969253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-encoded biosynthetic genes alleviate metabolic disadvantages while increasing glucose conversion to shikimate in an engineered Escherichia coli strain.
    Rodriguez A; Martínez JA; Millard P; Gosset G; Portais JC; Létisse F; Bolivar F
    Biotechnol Bioeng; 2017 Jun; 114(6):1319-1330. PubMed ID: 28186321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Escherichia coli for the synthesis of short- and medium-chain α,β-unsaturated carboxylic acids.
    Kim S; Cheong S; Gonzalez R
    Metab Eng; 2016 Jul; 36():90-98. PubMed ID: 26996381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives.
    Noda S; Shirai T; Oyama S; Kondo A
    Metab Eng; 2016 Jan; 33():119-129. PubMed ID: 26654797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Escherichia coli to produce branched-chain fatty acids in high percentages.
    Bentley GJ; Jiang W; Guamán LP; Xiao Y; Zhang F
    Metab Eng; 2016 Nov; 38():148-158. PubMed ID: 27421620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial pathway optimization in Escherichia coli by directed co-evolution of rate-limiting enzymes and modular pathway engineering.
    Lv X; Gu J; Wang F; Xie W; Liu M; Ye L; Yu H
    Biotechnol Bioeng; 2016 Dec; 113(12):2661-2669. PubMed ID: 27316379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient production of the Nylon 12 monomer ω-aminododecanoic acid methyl ester from renewable dodecanoic acid methyl ester with engineered Escherichia coli.
    Ladkau N; Assmann M; Schrewe M; Julsing MK; Schmid A; Bühler B
    Metab Eng; 2016 Jul; 36():1-9. PubMed ID: 26969251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the biological conversion of methanol to specialty chemicals in Escherichia coli.
    Whitaker WB; Jones JA; Bennett RK; Gonzalez JE; Vernacchio VR; Collins SM; Palmer MA; Schmidt S; Antoniewicz MR; Koffas MA; Papoutsakis ET
    Metab Eng; 2017 Jan; 39():49-59. PubMed ID: 27815193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homo-succinic acid production by metabolically engineered Mannheimia succiniciproducens.
    Lee JW; Yi J; Kim TY; Choi S; Ahn JH; Song H; Lee MH; Lee SY
    Metab Eng; 2016 Nov; 38():409-417. PubMed ID: 27746096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.